CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma.
Oncoimmunology
; 10(1): 2000699, 2021.
Article
in En
| MEDLINE
| ID: mdl-34777918
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Single-Domain Antibodies
/
Multiple Myeloma
Limits:
Animals
/
Humans
Language:
En
Journal:
Oncoimmunology
Year:
2021
Type:
Article
Affiliation country:
Belgium